Institution Information
Reportee Signature Date Report period Total Entries Total AUM($)
VERSANT VENTURE MANAGEMENT LLC 07-12-2019 06-30-2019 9 343,186,489
Institutional Holdings
Issuer Class Position Value Shares Portfolio Percentage (%) Previous Percentage (%) Shares Delta Shares Delta(%)
CRISPR Therapeutics AG Common Stock 1 $200,122,625 4,248,888 0.06 0.05 0 0.00
Veracyte, Inc. Common Stock 2 $68,732,336 2,410,815 0.02 0.03 -1,205,406 -33.33
Gritstone Oncology, Inc. Common Stock 3 $34,566,629 3,102,929 0.01 3,102,929 +Inf
Audentes Therapeutics, Inc. Common Stock 4 $20,971,260 553,916 0.01 0.01 -249,190 -31.03
Ocular Therapeutix, Inc. Common Stock 5 $9,747,690 2,215,384 0.00 0.00 0 0.00
CymaBay Therapeutics, Inc. Common Stock 6 $3,893,270 543,753 0.00 0.00 -540,943 -49.87
Second Sight Medical Products, Inc. Common Stock 7 $3,597,974 4,492,975 0.00 0.00 0 0.00
8
Clovis Oncology, Inc. Common Stock 9 $1,514,584 101,855 0.00 0.00 0 0.00
10
OpGen, Inc. Common Stock 11 $40,121 102,167 0.00 0.00 0 0.00
Debug Info- Version: 2.1